🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian here - our healthcare covers everything EXCEPT this apparently — 12 month update Page 5

Canadian here - our healthcare covers everything EXCEPT this apparently — 12 month update

MASHdoc_SA Wed, Feb 7, 2024 at 10:34 AM 31 replies 2,291 viewsPage 5 of 7
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 12, 2024 at 6:56 PM#21

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

12 12Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 9 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Feb 14, 2024 at 2:37 AM#22

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

11 11hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 8 others
Reply Quote Save Share Report
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Feb 15, 2024 at 10:17 AM#23
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

This is where I part company with the consensus forming above. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

10 10maya_sedona, stefan_berlin, Dr.EM_Chicago and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Feb 16, 2024 at 5:57 PM#24
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

Correct me if the detail matters more than I have assumed.

9 9robert_kc, dan_philly, MeganSA_TX and 6 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Feb 18, 2024 at 1:36 AM#25
TrialTracker_MD said:
One habit that pays for itself: post the method alongside the number.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

8 8mel_PDX, Dr.AddMedPHL, newstart_MO and 5 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register